REG - Applied Nutrition - H1 FY26 Trading Update

Applied NutritionAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260217:nRSQ2432Ta&default-theme=true

RNS Number : 2432T  Applied Nutrition PLC  17 February 2026

For release 7:00am 17 February 2026

 

Applied Nutrition plc

(the "Group")

H1 FY26 Trading Update

 

Applied Nutrition plc, a leading sports nutrition, health and wellness brand,
today announces an update on trading for the six months ended 31 January 2026
("H1 FY26").

 

H1 FY26(1) Trading Update

The Group delivered a very strong performance in the first half of the
financial year, generating revenue of £74.5 million, an increase of 57% on H1
FY25 (£47.6 million). EBITDA for the period was also ahead of management
expectations.

As noted in the December Trading Update, the Group entered the January peak
Health, Fitness & Wellbeing period with retail orders and resultant
customer stock levels, significantly above expectations. This is a consequence
of the success of its channel diversification across UK high street health
retailers, grocers and discounters.  Together with accelerated demand for a
number of H1 FY26 product launches, this is expected to result in a more
H1‑weighted revenue profile than in prior years.

FY26 Outlook(2
) Reflecting the strong first‑half performance, the Group now anticipates that FY26 results will be ahead of updated market consensus expectations(3).  Management currently expects full‑year revenue of approximately £140 million.

 

Notice of Results

The Group will announce its Interim Results for the six months ended 31
January 2026 on 23 March 2026.

 

Analyst Presentation

Thomas Ryder, CEO, Steven Granite, COO and Joe Pollard, CFO, will host a
virtual presentation and Q&A session for analysts at 09.00 GMT on 23 March
2026.

 

To register, please email appliednutrition@almastrategic.com
(mailto:appliednutrition@almastrategic.com)

 

Retail Investor Presentation

Management will also host a virtual presentation and Q&A session for
retail investors at 16.00 GMT on 23 March 2026.

 

To register to attend, please use the following link:
https://engageinvestor.news/APN_IP_0326
(https://engageinvestor.news/APN_IP_0326)

 

 

Notes:

(1) All figures used in this announcement relating to FY26 remain subject to
audit.

 

(2) Please see cautionary note regarding forward-looking statements below.

( )

(3) Consensus market expectations for FY26 as calculated by the Company
immediately before this announcement are:

 Measure          FY26
 Revenue          £133.5 million
 Adjusted EBITDA  £37.7 million

 

The Company periodically updates these calculations and publishes them at:
https://www.appliednutritionplc.com/consensus-earnings-estimates
(https://www.appliednutritionplc.com/consensus-earnings-estimates)

 

 

Further information and contacts

 

Information for investors can be found on the Group's website at
www.appliednutritionplc.com (http://www.appliednutritionplc.com)

 

 Applied Nutrition plc                                             via Alma
 Thomas Ryder, Chief Executive Officer
 Steven Granite, Chief Operating Officer
 Joe Pollard, Chief Financial Officer

 Alma Strategic Communications                                     +44 (0) 203 405 0205

 (Public Relations adviser to Applied Nutrition)                   appliednutrition@almastrategic.com
 Rebecca Sanders-Hewett, Sam Modlin, Joe Pederzolli, Sarah Peters

 

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation.  The person responsible for arranging the
release of this announcement on behalf of Applied Nutrition is Joe Pollard,
Chief Financial Officer.

 

Forward-looking statements

 

Cautionary Statement - Certain statements included or incorporated by
reference within this announcement may constitute "forward-looking statements"
in respect of the Group's operations, performance, prospects and/or financial
condition. Forward-looking statements are sometimes, but not always,
identified by their use of a date in the future or such words and words of
similar meaning as "anticipates", "aims", "due", "could", "may", "will",
"should", "expects", "believes", "intends", "plans", "potential", "targets",
"goal" or "estimates". By their nature, forward looking statements involve a
number of risks, uncertainties and assumptions and actual results or events
may differ materially from those expressed or implied by those statements.
Accordingly, no assurance can be given that any particular expectation will be
met, and reliance should not be placed on any forward-looking statement.
Additionally, forward-looking statements regarding past trends or activities
should not be taken as a representation that such trends or activities will
continue in the future. No responsibility or obligation is accepted to update
or revise any forward-looking statement resulting from new information, future
events or otherwise. Nothing in this announcement should be construed as a
profit forecast. This announcement does not constitute or form part of any
offer or invitation to sell, or any solicitation of any offer to purchase any
shares or other securities in the Company, nor shall it or any part of it or
the fact of its distribution form the basis of, or be relied on in connection
with, any contract or commitment or investment decisions relating thereto, nor
does it constitute a recommendation regarding the shares or other securities
of the Company. Past performance cannot be relied upon as a guide to future
performance and persons needing advice should consult an independent financial
adviser. Statements in this announcement reflect the knowledge and information
available at the time of its preparation. Liability arising from anything in
this announcement shall be governed by English law. Nothing in this
announcement shall exclude any liability under applicable laws that cannot be
excluded in accordance with such laws.

 

Notes to editors

 

Applied Nutrition plc (LSE: APN) is a leading sports nutrition, health and
wellness brand, which formulates and creates nutrition products with a stated
aim of being the world's most trusted and innovative brand in the market.

 

Headquartered in the UK, the Group sells products in over 85 countries
worldwide and has a diverse product range, targeting elite athletes, gym goers
and health-conscious consumers. Applied Nutrition has developed and launched
four ranges under the umbrella of the Applied Nutrition brand - Applied
Nutrition, ABE, BodyFuel, and Endurance. Across the four ranges, the Group
sells over 120 different products.

 

The Group's success has been built on an exceptional product range developed
in-house in Knowsley, Liverpool, by a team of experts, allowing products to be
developed efficiently delivering new innovation to the market, keeping
existing products up to date, and introducing products aligned with latest
trends.

 

The Group largely operates a global business-to-business (B2B) model, which
has facilitated a low risk, highly cost-effective go-to-market strategy and
has enabled strong, profitable growth in the UK, Europe and other
international geographies. The business model and strategy has enabled the
Group to become a fast-growing, highly profitable and cash generative global
supplier in the sports nutrition, health and wellness market.

 

For further information, please visit www.appliednutritionplc.com
(http://www.appliednutritionplc.com)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTTFMLTMTBBBRF



            Copyright 2019 Regulatory News Service, all rights reserved